From the miRoncol archive: This update is presented in its original historical context. Current platform and product information is available throughout the main website.
We are thrilled to announce the establishment of miRoncol’s Business Advisory Board in April 2024. This group of experts is dedicated to providing strategic advice and guidance to advance our mission of revolutionizing cancer detection and democratizing access to early detection with accurate, affordable multi-cancer early blood tests.
Our board members include:
- Beth Rogozinski, CEO, Oncoustics
- Jiah Pearson-Leary, PhD, CEO, Spire Bio Advisory
- Vinona Bhatia, MD, MPH, Principal, Atapir